These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 2844392)

  • 1. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL; Cory JG
    Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
    Cory AH; Sato A; Thompson DP; Cory JG
    Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG; Carter GL
    Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combinations of drugs having different modes of action at the ribonucleotide reductase site on growth of L1210 cells in culture.
    Sato A; Carter GL; Bacon PE; Cory JG
    Cancer Res; 1982 Nov; 42(11):4353-7. PubMed ID: 6751522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo growth of mouse leukemia L1210 cells with metabolic alterations in the subunits of ribonucleotide reductase.
    Somerville L; Cory AH; Cory JG
    In Vivo; 2002; 16(3):175-7. PubMed ID: 12182112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
    Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
    Cory JG; Sato A; Carter GL; Bacon PE; Montgomery JA; Brown NC
    Adv Enzyme Regul; 1985; 23():181-92. PubMed ID: 3907303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase.
    Carter GL; Cory JG
    Adv Enzyme Regul; 1989; 29():123-39. PubMed ID: 2699151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
    Lewis WH; Wright JA
    J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyribonucleotide metabolism and cyclic AMP resistance in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Gudas LJ; Nodzenski E
    J Cell Physiol; 1987 Feb; 130(2):262-9. PubMed ID: 3029148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cells.
    Weckbecker G; Weckbecker A; Lien EJ; Cory JG
    Cancer Res; 1987 Feb; 47(4):975-8. PubMed ID: 2433036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased ribonucleotide reductase activity in hydroxyurea-resistant mosquito cells.
    Gerenday A; Shih KM; Herman CC; Fallon AM
    Arch Insect Biochem Physiol; 2001; 46(1-2):19-25. PubMed ID: 11276057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-hydroxy-N'-aminoguanidine isoquinoline in combination with other inhibitors of ribonucleotide reductase on L1210 cells.
    Weckbecker G; Weckbecker A; Lien EJ; Cory JG
    J Natl Cancer Inst; 1988 Jun; 80(7):491-6. PubMed ID: 2452889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
    Sato A; Montgomery JA; Cory JG
    Cancer Res; 1984 Aug; 44(8):3286-90. PubMed ID: 6611198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N'-aminoguanidine derivatives.
    Cory JG; Carter GL; Bacon PE; T'ang A; Lien EJ
    Biochem Pharmacol; 1985 Aug; 34(15):2645-50. PubMed ID: 3893440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-carbamoyloxyurea-resistant Chinese hamster ovary cells with elevated levels of ribonucleotide reductase activity.
    Hards RG; Wright JA
    J Cell Physiol; 1981 Feb; 106(2):309-19. PubMed ID: 7012160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
    Zhou BS; Hsu NY; Pan BC; Doroshow JH; Yen Y
    Cancer Res; 1995 Mar; 55(6):1328-33. PubMed ID: 7882331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of biochemical modulation of drug combinations directed at the ribonucleotide reductase site on leukemia L1210 cell growth in culture.
    Sato A; Carter GL; Bacon PE; Cory JG
    Adv Enzyme Regul; 1983; 21():259-70. PubMed ID: 6400064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural aspects of N-hydroxy-N'-aminoguanidine derivatives as inhibitors of L1210 cell growth and ribonucleotide reductase activity.
    Cory JG; Cory AH; Raber NK; Narayanan A; Schneller SW
    Adv Enzyme Regul; 1993; 33():129-40. PubMed ID: 8356905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
    Cory JG; Fleischer AE
    Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.